Klaus Brischwein

Merck (Germany)Germany

Medicine · Health Sciences

17h-index1.9kcitations26works0.02yr avg

Accepting Students?

No reports yet. Know if this professor is taking students?


Research Topics

Monoclonal and Polyclonal Antibodies Research(18), CAR-T cell therapy research(13), Glycosylation and Glycoproteins Research(6), Immunotherapy and Immune Responses(4), Immune Cell Function and Interaction(3)

Publications26 total

Therapeutic window of MuS110, a single-chain antibody construct bispecific for EpCAM (CD326) and CD3
Molecular Cancer Therapeutics·2007· 3 cited
Mode of action of MT110, a novel bispecific single-chain antibody construct of the BiTE class for treatment of adeno and squamous cell carcinoma expressing EpCAM (CD326)
2007· 1 cited
page 1 of 2Next →

Frequent Co-authors

Patrick A. Baeuerle(20), Peter Kufer(15), Bernd Schlereth(13), Grit Lorenczewski(8), Mathias Locher(7), Roman Kischel(6), Robert Hofmeister(5), Ralf Lutterbuese(5), Larissa Parr(5), Petra Lutterbuese(5), Maria Amann(4), Volker Gekeler(4), Peter Bader(4), Patrick Hoffmann(3), Sandrine Crommer(3), Nadja Prang(3), Petra Kleindienst(3), Iduna Fichtner(3), Stefan Pflanz(3), Jörg Volkland(3)